Us Bancorp \De\ Beyond Spring Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$1.68 - $5.01 $3,150 - $9,393	-1,875 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$4.02 - $16.84 $2,508 - $10,508	-624 Reduced 24.97%	1,875 $8,000
Q3 2021 Nov 10, 2021	BUY	$9.26 - $31.31 $22,520 - $76,145	2,432 Added 3629.85%	2,499 $39,000
Q2 2021 Aug 05, 2021	BUY	$9.37 - $12.12 $627 - $812	67 New	67 $1,000

5.28M

200

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $65M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.